|
Cephalon to Expedite FDA Application
|
| Pharmaceutical firm Cephalon Inc. said Thursday that it plans to speed up submitting its drug modafinil for regulatory approval after three late-stage trials showed the drug improved symptoms of attention deficit hyperactivity disorder in children. |
|
| Updated |
Aug 19, 2004 20:07:02 |
| Rating |
0 | | Author | Forbes |
|
|
| Similar news: | - Mortgage Applications Fall - New applications for U.S. mortgagesfell more than 4 percent last week reversing two straight weeksof increases, as interest rates on the 30-year mortgages wereunchanged, an industry group said on Wednesday.
- Mortgage Applications Down Last Week - Applications for U.S. home mortgagesdecreased last week as a drop in home purchasing activityoffset a marginal increase in refinancing, amid a rise ininterest rates, an industry group said on Wednesday.
| | Find all news similar on Cephalon to Expedite FDA Application |
|